We caught up with Dr José Merino (Arrhythmia and Robotic Electrophysiology Unit, La Paz University Hospital, and Universidad Autónoma de Madrid, Madrid, Spain) on the new ESC guidelines for atrial fibrillation.
- What are the limitations of current ablation treatments for patients with atrial fibrillation? (0.22)
- What are the major changes in the latest ESC atrial fibrillation guidelines? (3.08)
- What are your thoughts on the changes in guidelines relating to ablation procedures? (5.16)
- What are the implications of these new guidelines for clinical practice? (7.08)
- What are the major gaps in our knowledge and how can these be overcome? (8.37)
Speaker disclosures: Dr José Merino has received research and education contracts and fees from Abbott, Boston Scientific and Medtronic.
Support: Commissioned, edited and funded by Touch Medical Media.
Filmed during a remote video call with Dr José Merino, September 2020.
Share this Video
Related Videos In Atrial Fibrillation
Faizel Osman, A-A Heart Rhythm Updates 2021: 2020 ESC AF Guidelines
We spoke to Professor Faizel Osman (Consultant Cardiologist and Electrophysiologist, University Hospital Coventry and Warwickshire NHS Trust, Coventry, UK) who gave us an update about the recent new ESC Guidelines for Atrial Fibrillation and the upcoming Arrhythmia Alliance Heart Rhythm Updates 2021. Questions What are the most important new recommendations in the 2020 ESC atrial […]
Suneet Mittal, AF Symposium 2021: Atrial Fibrillation in the Post-COVID-19 Environment
We spoke to Dr Suneet Mittal (Director of Electrophysiology, The Valley Hospital, Ridgewood, NJ, USA) about the workflow innovations for atrial fibrillation ablation in the post-COVID-19 environment. Questions What have been the main challenges to atrial fibrillation (AF) ablation workflow during the COVID-19 pandemic? (0.14) What workflow innovations have been created and incorporated over the […]
Hugh Calkins, AF Symposium 2021: the STOP Persistent AF Clinical Trial
We spoke to Professor Hugh Calkins (Johns Hopkins Hospital, Baltimore, MD, USA) about the STOP Persistent AF Clinical Trial (NCT03012841). Questions: Could you tell us a little about the aims and design of the STOP Persistent AF clinical trial? (0.13) What were the findings of the study? (0.43) What are their implications for clinical practice? […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!